BioSpace News Archive

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed the previously announced acquisition of Stirling Ultracold (“Stirling”),

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced C. Jeff Dekker as its Chief Financial Officer, effective May 10, 2021,

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, will be providing first quarter 2021 results and a general business update on May 10, 2021.

The Dow Chemical Company, a wholly owned subsidiary of Dow Inc., announced a full redemption of its 3.50% Notes due October 2024 and of its 3.15% Notes due May 2024 issued pursuant to an Indenture dated as of May 1, 2008 between TDCC and The Bank of New York Mellon Trust Company, N.A., as trustee.

Kepro announced today that it has acquired substantially all the assets of Independent Medical Expert Consulting Services, Inc. (IMEDECS), a URAC-accredited independent medical review services company that provides peer review, external appeals and dispute resolution services to health plans. 

Teligent, Inc., a New Jersey-based generics pharmaceutical company, announced its financial results for the fourth quarter and year ended December 31, 2020.

HCmed announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring’s plasma derived immunoglobulin administered via HCmed’s new generation vibrating-mesh nebulizing device.

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Pixee Medical, a France-based supplier of high-performance computer-assisted surgery solutions, has received 510K clearance from the U.S. Food and Drug Administration (FDA) for its Knee+ total knee replacement surgery

Following the success of more than 700 vaccination clinics across the country hosted primarily at churches and community centers, Walgreens will activate multiple mobile clinics in Chicago.

The partnership with Fluence expands Tryp’s ability to conduct comprehensive clinical trials and leverage invaluable experience and insight from the leader in psychedelic therapy training